{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:17:33Z","timestamp":1768871853959,"version":"3.49.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231252","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T17:32:47Z","timestamp":1586971967000},"page":"e0231252","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["A compound attributes-based predictive model for drug induced liver injury in humans"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7021-0175","authenticated-orcid":true,"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudong D.","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"issue":"3","key":"pone.0231252.ref001","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical R&D efficiency","volume":"11","author":"JW Scannell","year":"2012","journal-title":"Nature reviews Drug discovery"},{"issue":"6","key":"pone.0231252.ref002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework","volume":"13","author":"D Cook","year":"2014","journal-title":"Nature reviews Drug discovery"},{"key":"pone.0231252.ref003","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.taap.2017.09.006","article-title":"Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: The IQ consortium nonclinical to clinical translational database","volume":"334","author":"TM Monticello","year":"2017","journal-title":"Toxicology and applied pharmacology"},{"issue":"2","key":"pone.0231252.ref004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ddr.20415","article-title":"In Silico Augmentation of the Drug Development Pipeline: Examples from the study of Acute Inflammation","volume":"72","author":"G An","year":"2011","journal-title":"Drug development research"},{"issue":"4","key":"pone.0231252.ref005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425250903499286","article-title":"A structural feature-based computational approach for toxicology predictions","volume":"6","author":"LG Valerio","year":"2010","journal-title":"Expert opinion on drug metabolism & toxicology"},{"issue":"9","key":"pone.0231252.ref006","doi-asserted-by":"crossref","first-page":"e105889","DOI":"10.1371\/journal.pone.0105889","article-title":"A systematic investigation of computation models for predicting Adverse Drug Reactions (ADRs)","volume":"9","author":"Q Kuang","year":"2014","journal-title":"PloS one"},{"issue":"9","key":"pone.0231252.ref007","first-page":"498","article-title":"Integrating Multiple Evidence Sources to Predict Adverse Drug Reactions Based on a Systems Pharmacology Model","volume":"4","author":"DS Cao","year":"2015","journal-title":"CPT: pharmacometrics & systems pharmacology"},{"issue":"125","key":"pone.0231252.ref008","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003377","article-title":"Data-driven prediction of drug effects and interactions","volume":"4","author":"NP Tatonetti","year":"2012","journal-title":"Science translational medicine"},{"issue":"10","key":"pone.0231252.ref009","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.chembiol.2016.07.023","article-title":"A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials","volume":"23","author":"KM Gayvert","year":"2016","journal-title":"Cell chemical biology"},{"issue":"Suppl 5","key":"pone.0231252.ref010","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1471-2164-12-S5-S11","article-title":"Predicting adverse side effects of drugs","volume":"12","author":"LC Huang","year":"2011","journal-title":"BMC genomics"},{"issue":"7","key":"pone.0231252.ref011","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1517\/17425255.2013.783819","article-title":"Development of cardiac safety translational tools for QT prolongation and torsade de pointes","volume":"9","author":"LG Valerio","year":"2013","journal-title":"Expert opinion on drug metabolism & toxicology"},{"issue":"1","key":"pone.0231252.ref012","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"B Sassolas","year":"2010","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"15","key":"pone.0231252.ref013","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/bioinformatics\/btw168","article-title":"Drug-induced adverse events prediction with the LINCS L1000 data","volume":"32","author":"Z Wang","year":"2016","journal-title":"Bioinformatics"},{"issue":"8","key":"pone.0231252.ref014","doi-asserted-by":"crossref","first-page":"e0134208","DOI":"10.1371\/journal.pone.0134208","article-title":"Identification of Adverse Drug Events from Free Text Electronic Patient Records and Information in a Large Mental Health Case Register","volume":"10","author":"E Iqbal","year":"2015","journal-title":"PloS one"},{"issue":"6","key":"pone.0231252.ref015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/clpt.2013.24","article-title":"Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system","volume":"93","author":"R Harpaz","year":"2013","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"7","key":"pone.0231252.ref016","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nbt.3623","article-title":"Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data","volume":"34","author":"M Sarangdhar","year":"2016","journal-title":"Nature biotechnology"},{"key":"pone.0231252.ref017","doi-asserted-by":"crossref","first-page":"160026","DOI":"10.1038\/sdata.2016.26","article-title":"A curated and standardized adverse drug event resource to accelerate drug safety research","volume":"3","author":"JM Banda","year":"2016","journal-title":"Scientific data"},{"issue":"5","key":"pone.0231252.ref018","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/clpt.2014.17","article-title":"Exploring the FDA adverse event reporting system to generate hypotheses for monitoring of disease characteristics","volume":"95","author":"H Fang","year":"2014","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"6","key":"pone.0231252.ref019","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"N Chalasani","year":"2008","journal-title":"Gastroenterology"},{"issue":"12","key":"pone.0231252.ref020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archinte.165.12.1363","article-title":"Adverse drug event surveillance and drug withdrawals in the United States, 1969\u20132002: the importance of reporting suspected reactions","volume":"165","author":"DK Wysowski","year":"2005","journal-title":"Archives of internal medicine"},{"issue":"17","key":"pone.0231252.ref021","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.287.17.2215","article-title":"Timing of new black box warnings and withdrawals for prescription medications","volume":"287","author":"KE Lasser","year":"2002","journal-title":"Jama"},{"key":"pone.0231252.ref022","doi-asserted-by":"crossref","unstructured":"Jahid MJ, Ruan J. An Ensemble Approach for Drug Side Effect Prediction. Proceedings IEEE International Conference on Bioinformatics and Biomedicine. 2013:440\u20135.","DOI":"10.1109\/BIBM.2013.6732532"},{"key":"pone.0231252.ref023","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1471-2105-12-169","article-title":"Predicting drug side-effect profiles: a chemical fragment-based approach","volume":"12","author":"E Pauwels","year":"2011","journal-title":"BMC bioinformatics"},{"key":"pone.0231252.ref024","doi-asserted-by":"crossref","first-page":"8809","DOI":"10.1038\/srep08809","article-title":"3D pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance","volume":"5","author":"S Vilar","year":"2015","journal-title":"Scientific reports"},{"issue":"7403","key":"pone.0231252.ref025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature11159","article-title":"Large-scale prediction and testing of drug activity on side-effect targets","volume":"486","author":"E Lounkine","year":"2012","journal-title":"Nature"},{"key":"pone.0231252.ref026","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13321-016-0147-1","article-title":"Leveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associations","volume":"8","author":"S Vilar","year":"2016","journal-title":"Journal of cheminformatics"},{"key":"pone.0231252.ref027","first-page":"e137","article-title":"Similarity-based modeling applied to signal detection in pharmacovigilance","volume":"3","author":"S Vilar","year":"2014","journal-title":"CPT: pharmacometrics & systems pharmacology"},{"issue":"6","key":"pone.0231252.ref028","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/cmdc.200700026","article-title":"Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure","volume":"2","author":"A Bender","year":"2007","journal-title":"ChemMedChem"},{"issue":"1","key":"pone.0231252.ref029","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/clpt.2009.248","article-title":"Prediction of adverse drug reactions using decision tree modeling","volume":"88","author":"F Hammann","year":"2010","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"1","key":"pone.0231252.ref030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","article-title":"A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development","volume":"136","author":"RE Morgan","year":"2013","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"issue":"6","key":"pone.0231252.ref031","first-page":"401","article-title":"Hepatotoxicity associated with ticrynafen\u2014a uricosuric diuretic","volume":"77","author":"JW Manier","year":"1982","journal-title":"The American journal of gastroenterology"},{"key":"pone.0231252.ref032","article-title":"Predicting Drug-Induced Liver Injury with Bayesian Machine Learning","author":"DP Williams","year":"2019","journal-title":"Chem Res Toxicol"},{"issue":"3\u20134","key":"pone.0231252.ref033","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/minf.201500055","article-title":"In silico Prediction of Drug Induced Liver Toxicity Using Substructure Pattern Recognition Method","volume":"35","author":"C Zhang","year":"2016","journal-title":"Mol Inform"},{"issue":"1","key":"pone.0231252.ref034","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/toxsci\/kfy121","article-title":"Predicting Drug-Induced Liver Injury Using Ensemble Learning Methods and Molecular Fingerprints","volume":"165","author":"H Ai","year":"2018","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"issue":"5","key":"pone.0231252.ref035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1517\/14740338.4.5.929","article-title":"The role of data mining in pharmacovigilance","volume":"4","author":"M Hauben","year":"2005","journal-title":"Expert opinion on drug safety"},{"issue":"2","key":"pone.0231252.ref036","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"RE Morgan","year":"2010","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T17:33:14Z","timestamp":1586971994000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231252"}},"subtitle":[],"editor":[{"given":"Jed N.","family":"Lampe","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231252","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]}}}